Narrowing of spaces in the spine, which can cause pressure on the spinal cord and nerves, resulting in chronic pain.
Pain radiating along the sciatic nerve, usually from the lower back down through the legs. It may be covered under broader back and leg pain categories but is not specifically FDA-approved.
Pain from nerve root compression or inflammation, often resulting in back or leg pain. SCS can be used, though FDA approval is focused on broader categories of back and leg pain.
Chronic pain after spinal decompression surgery (laminectomy), often considered part of FBSS.
Peripheral Vascular Disease (PVD)
Chronic pain related to poor circulation in the limbs, particularly the legs.
Chronic pain following a shingles outbreak, which affects nerve fibers and skin.
Damage to peripheral nerves causing numbness, tingling, and pain, often in the hands and feet. FDA approval depends on the specific condition.
Chronic pain due to nerve damage from diabetes, affecting extremities (hands, feet).
Chronic nerve pain caused by nerve damage from MS, though not specifically FDA-approved.
Persistent or recurring pain following one or more spine surgeries.
Chronic pain caused by wear and tear of the discs in the spine, typically leading to lower back pain.
Complex Regional Pain Syndrome
A chronic pain condition affecting a limb after injury or surgery, with disproportionate pain to the injury.
SCS can be used to manage chronic pain associated with cancer, but it is not specifically FDA-approved for this use.
SCS is used for chronic angina not relieved by medication or surgery, though not FDA-approved in the U.S.
Inflammation of the arachnoid membrane around the spinal cord, often leading to chronic pain and nerve damage.